BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32568101)

  • 1. Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia.
    Chen SL; Hu F; Wang DW; Qin ZY; Liang Y; Dai YJ
    Aging (Albany NY); 2020 Jun; 12(12):11864-11877. PubMed ID: 32568101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
    Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
    Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
    Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
    Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia.
    Cremer A; Ellegast JM; Alexe G; Frank ES; Ross L; Chu SH; Pikman Y; Robichaud A; Goodale A; Häupl B; Mohr S; Rao AV; Walker AR; Blachly JS; Piccioni F; Armstrong SA; Byrd JC; Oellerich T; Stegmaier K
    Cancer Discov; 2020 Feb; 10(2):214-231. PubMed ID: 31771968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCAMP2/5 as diagnostic and prognostic markers for acute myeloid leukemia.
    Yue C; Xie S; Zhong J; Zhao H; Lin Z; Zhang L; Xu B; Luo Y
    Sci Rep; 2021 Aug; 11(1):17012. PubMed ID: 34426610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML.
    Ruvolo PP; Hu CW; Qiu Y; Ruvolo VR; Go RL; Hubner SE; Coombes KR; Andreeff M; Qutub AA; Kornblau SM
    EBioMedicine; 2019 Jun; 44():126-137. PubMed ID: 31105032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADCY7 supports development of acute myeloid leukemia.
    Li C; Xie J; Lu Z; Chen C; Yin Y; Zhan R; Fang Y; Hu X; Zhang CC
    Biochem Biophys Res Commun; 2015 Sep; 465(1):47-52. PubMed ID: 26220344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia.
    Liu Y; Lu R; Cui W; Pang Y; Liu C; Cui L; Qian T; Quan L; Dai Y; Jiao Y; Pan Y; Ye X; Shi J; Cheng Z; Fu L
    Cancer Gene Ther; 2020 Feb; 27(1-2):38-44. PubMed ID: 30923336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
    Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Expression of VAV Gene Family Predicts Poor Prognosis of Acute Myeloid Leukemia.
    Mu D; Long S; Guo L; Liu W
    Technol Cancer Res Treat; 2021; 20():15330338211065877. PubMed ID: 34894858
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct prognostic values of Annexin family members expression in acute myeloid leukemia.
    Niu Y; Yang X; Chen Y; Jin X; Xie Y; Tang Y; Li L; Liu S; Guo Y; Li X; Duan L; Wang H
    Clin Transl Oncol; 2019 Sep; 21(9):1186-1196. PubMed ID: 30694461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia.
    Pan JQ; Zhang YQ; Wang JH; Xu P; Wang W
    Int J Mol Med; 2017 Mar; 39(3):663-671. PubMed ID: 28204819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased SYK activity is associated with unfavorable outcome among patients with acute myeloid leukemia.
    Boros K; Puissant A; Back M; Alexe G; Bassil CF; Sinha P; Tholouli E; Stegmaier K; Byers RJ; Rodig SJ
    Oncotarget; 2015 Sep; 6(28):25575-87. PubMed ID: 26315286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia.
    Espinoza JL; Elbadry MI; Taniwaki M; Harada K; Trung LQ; Nakagawa N; Takami A; Ishiyama K; Yamauchi T; Takenaka K; Nakao S
    Cancer Lett; 2017 Aug; 400():127-136. PubMed ID: 28456658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD37 high expression as a potential biomarker and association with poor outcome in acute myeloid leukemia.
    Zhang Q; Han Q; Zi J; Song C; Ge Z
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32400873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia.
    Bertoli S; Paubelle E; Bérard E; Saland E; Thomas X; Tavitian S; Larcher MV; Vergez F; Delabesse E; Sarry A; Huguet F; Larrue C; Bosc C; Farge T; Sarry JE; Michallet M; Récher C
    Eur J Haematol; 2019 Feb; 102(2):131-142. PubMed ID: 30325535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
    Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
    Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
    [No Abstract]   [Full Text] [Related]  

  • 19. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.